Intrahepatic Cholangiocarcinoma, Annals of Surgery, vol.248, issue.1, pp.84-96, 2008. ,
DOI : 10.1097/SLA.0b013e318176c4d3
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma, Gastroenterology, vol.145, issue.6, pp.1215-1244, 2013. ,
DOI : 10.1053/j.gastro.2013.10.013
Cancer statistics, 2014, CA: A Cancer Journal for Clinicians, vol.112, issue.suppl 5, pp.9-29, 2014. ,
DOI : 10.3322/caac.21208
Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies, Journal of the American College of Surgeons, vol.217, issue.4, pp.736-750, 2013. ,
DOI : 10.1016/j.jamcollsurg.2013.05.021
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, vol.33, issue.6, pp.1353-1360, 2001. ,
DOI : 10.1053/jhep.2001.25087
Clinical presentation and management of intrahepatic cholangiocarcinoma, Gastroent??rologie Clinique et Biologique, vol.34, issue.3, pp.191-200, 2010. ,
DOI : 10.1016/j.gcb.2010.01.006
Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study, Annals of Surgical Oncology, vol.70, issue.2, pp.600-608, 2008. ,
DOI : 10.1245/s10434-007-9627-x
Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis, Journal of Gastrointestinal Surgery, vol.20, issue.6, pp.1488-96, 2007. ,
DOI : 10.1007/s11605-007-0282-0
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival, British Journal of Surgery, vol.166, issue.12, pp.1525-1556, 2002. ,
DOI : 10.1046/j.1365-2168.2002.02268.x
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma, Gastroenterology, vol.127, issue.5, pp.194-205, 2004. ,
DOI : 10.1053/j.gastro.2004.09.034
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis, European Radiology, vol.23, issue.Suppl 1, pp.951-960, 2009. ,
DOI : 10.1007/s00330-008-1211-7
Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres, Cancer, vol.18, issue.8, pp.2119-2147, 2008. ,
DOI : 10.1002/cncr.23818
Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option, Annals of Surgical Oncology, vol.16, issue.9493, pp.484-91, 2010. ,
DOI : 10.1245/s10434-009-0777-x
Yttrium-90 radioembolization for unresectable standardchemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study ,
Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1227-1261, 2013. ,
DOI : 10.1016/j.jvir.2013.02.031
Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?, Annals of Surgical Oncology, vol.118, issue.497???507, pp.2518-2543, 2013. ,
DOI : 10.1245/s10434-013-2906-9
Toxicity and response criteria of the Eastern Cooperative Oncology Group, AMERICAN JOURNAL OF CLINICAL ONCOLOGY, vol.5, issue.6, pp.649-55, 1982. ,
DOI : 10.1097/00000421-198212000-00014
Use and Dissemination of the Brisbane 2000 Nomenclature of Liver Anatomy and Resections, Annals of Surgery, vol.257, issue.3, pp.377-82, 2013. ,
DOI : 10.1097/SLA.0b013e31825a01f6
Surgical treatment of cholangiocarcinoma, Hepatogastroenterology, vol.44, pp.760-765, 1997. ,
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer, New England Journal of Medicine, vol.362, issue.14, pp.1273-81, 2010. ,
DOI : 10.1056/NEJMoa0908721
Single-Agent Gemcitabine for Biliary Tract Cancers, Oncology, vol.70, issue.5, pp.358-65, 2006. ,
DOI : 10.1159/000098109
Combination Chemotherapy With Gemcitabine and Cisplatin as First-Line Treatment for Immunohistochemically Proven Cholangiocarcinoma, American Journal of Clinical Oncology, vol.29, issue.2, pp.127-158, 2006. ,
DOI : 10.1097/01.coc.0000203742.22828.bb
Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial, Journal of Clinical Oncology, vol.23, issue.10, pp.2332-2340, 2005. ,
DOI : 10.1200/JCO.2005.51.008
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study, Annals of Oncology, vol.15, issue.9, pp.1339-1382, 2004. ,
DOI : 10.1093/annonc/mdh351
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival, CardioVascular and Interventional Radiology, vol.11, issue.33, pp.105-121 ,
DOI : 10.1007/s00270-011-0142-x
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis, Annals of Surgical Oncology, vol.141, issue.12, pp.3779-86, 2013. ,
DOI : 10.1245/s10434-013-3127-y
Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study, European Journal of Cancer, vol.49, issue.15, pp.3122-3152 ,
DOI : 10.1016/j.ejca.2013.05.012
One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization, World Journal of Gastroenterology, vol.20, issue.17, pp.5131-5135 ,
DOI : 10.3748/wjg.v20.i17.5131
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy, Journal of Clinical Oncology, vol.31, issue.9, pp.1188-95 ,
DOI : 10.1200/JCO.2012.41.5984
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma, JAMA Surgery, vol.149, issue.6, 2014. ,
DOI : 10.1001/jamasurg.2013.5137
Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review, World J Gastrointest Oncol, vol.6, pp.156-69, 2014. ,